OTC:AKBLF

ALK-Abello A/S Stock Forecast, Price & News

$469.00

0.00 (0.00%)

(As of 12/3/2021 12:00 AM ET)

Add

Compare

Today's Range: $469.00
▼
$469.00
50-Day Range: N/A
52-Week Range: $382.00
▼
$487.00

Volume: N/A
Average Volume: 100 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive AKBLF News and Ratings via Email

Sign-up to receive the latest news and ratings for ALK-Abello A/S and its competitors with MarketBeat's FREE daily newsletter.

About ALK-Abello A/S

ALK-Abello A/S engages in the production and development of pharmaceutical products to prevent and treat allergies. It also manufactures tablet-based allergy vaccines for pollen, house dust mites, animals, and insect stings. Its treatment comprises allergy vaccines, emergency treatment, and allergy diagnostics. The company was founded by Poul Christian Krejner Tejn Barfod on June 9, 1923 and is headquartered in Horsholm, Denmark.

ALK-Abello A/S (OTC:AKBLF) Downgraded by DNB Markets
November 12, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: OTC
Industry: Biotechnology
Sub-Industry: N/A
Sector: Health Technology
Current Symbol: OTC:AKBLF
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.alk.net
Phone: 45.45.74.75.76
Fax: N/A
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ALK-Abello A/S.

0.0 Community Rank

Outperform Votes
ALK-Abello A/S has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ALK-Abello A/S has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ALK-Abello A/S has received 100.00% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ALK-Abello A/S and other stocks. Vote “Outperform” if you believe AKBLF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AKBLF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ALK-Abello A/S does not currently pay a dividend.
Dividend Growth
ALK-Abello A/S does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ALK-Abello A/S insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

ALK-Abello A/S (OTC:AKBLF) Frequently Asked Questions

Is ALK-Abello A/S a buy right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ALK-Abello A/S in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ALK-Abello A/S stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKBLF, but not buy additional shares or sell existing shares.
View analyst ratings for ALK-Abello A/S or view top-rated stocks.
Who are some of ALK-Abello A/S's key competitors?: Some companies that are related to ALK-Abello A/S include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).
View all of AKBLF's competitors.
What is ALK-Abello A/S's stock symbol?: ALK-Abello A/S trades on the OTC under the ticker symbol "AKBLF."
How do I buy shares of ALK-Abello A/S?: Shares of AKBLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ALK-Abello A/S's stock price today?: One share of AKBLF stock can currently be purchased for approximately $469.00.
What is ALK-Abello A/S's official website?: The official website for ALK-Abello A/S is www.alk.net.
Where are ALK-Abello A/S's headquarters?: ALK-Abello A/S is headquartered at Bøge Allé 6-8, Hørsholm, Capital Region.
How can I contact ALK-Abello A/S?: ALK-Abello A/S's mailing address is Bøge Allé 6-8, Hørsholm, Capital Region. The company can be reached via phone at 45.45.74.75.76.

This page was last updated on 12/6/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.